SomaNautix

About:

Building an innovative Oncology Product company which exploits the unique physico-chemical properties of endoNaut technology.

Website: https://somanautix.com

Top Investors: UK Research and Innovation

Description:

SomaNautix is a spin out of the Battaglia Research group, University College London. Prof. Battaglia has been fascinated over many years by the powerful capability of viruses to penetrate cells. Applying some of the structural features of viruses to polymer constructs has resulted in the highly versatile, molecular engineered endoNaut technology for therapeutic rather than pathogenic purposes. Somanautix focuses on oncology product development for rare tumours (brain and peritoneal).

Total Funding Amount:

863000 GBP

Headquarters Location:

London, England, United Kingdom

Founded Date:

2017-06-05

Contact Email:

info(AT)somanautix.com

Founders:

Francesca Crawford

Number of Employees:

11-50

Last Funding Date:

2018-03-23

IPO Status:

Private

Industries:

© 2025 bioDAO.ai